reference/34390274

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34390274

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	2041-4889
issueIdentifier	9
pageRange	777-
publicationName	Cell Death & Disease
startingPage	777
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_eba3638310e8014999aa8e7355df5215 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab80a732b5df33e85751c0a758afb577
bibliographicCitation	Mejía-Hernández JO, Keam SP, Saleh R, Muntz F, Fox SB, Byrne D, Kogan A, Pang L, Huynh J, Litchfield C, Caramia F, Lozano G, He H, You JM, Sandhu S, Williams SG, Haupt Y, Haupt S. Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss. Cell Death & Disease. 2022 Sep 08;13(9):777. doi: 10.1038/s41419-022-05211-y.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_167ffdec8e63d23cf5373a3742268fa4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8292-1895 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_debfa1ea3a756ee402b2f122b3e3900f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27bbef3f3fbed39adcc2e4b0d78a6364 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7648-8896 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_042e42807bf044d41af9d0d0a487129f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9e762d93de5cceeeff613187473a203 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_85f120ede085c4cf3adc35e693d9f099 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7134-989X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_452c208ddf36fe02aec0b40a428481e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3733-1180 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ac266ab168194f444cde5fdc096355a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e64a0b97a3032515916ef26f49a35c6e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c60e0dd5f4fd96c2127098a852277811 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_257c3c850dd86c9cde2d47a5f3c40727 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b11709fb8f4577f417b032cd8c831dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9053-9138 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2484-1712 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8985-4886
date	2022-09-08^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/36075907 https://pubmed.ncbi.nlm.nih.gov/PMC9465983 https://doi.org/10.1038/s41419-022-05211-y
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37956 https://portal.issn.org/resource/ISSN/2041-4889
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss
discusses	http://id.nlm.nih.gov/mesh/M0479128 http://id.nlm.nih.gov/mesh/M0024670 http://id.nlm.nih.gov/mesh/M0282104
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016159Q000378 http://id.nlm.nih.gov/mesh/D016159Q000235 http://id.nlm.nih.gov/mesh/D011471Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011467Q000378 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D051059Q000378 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D051059Q000235 http://id.nlm.nih.gov/mesh/D063646Q000378 http://id.nlm.nih.gov/mesh/D004195 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D051379
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1b2452da84551fc91db93425b6a20d9 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bcd6f21312d21a5cf3f0a82f59d9ac97 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983

Showing number of triples: 1 to 61 of 61.